Literature DB >> 7916276

Clinical significance of diffuse delta EEG activity in chronic schizophrenia.

M Matsuura1, M Yoshino, K Ohta, H Onda, K Nakajima, T Kojima.   

Abstract

1) Forty-three chronic schizophrenics with diffuse delta activity (DDA) in their rest-awake EEGs were compared with 23 chronic schizophrenics with normal EEGs. 2) The DDA group was divided into three sub-groups according to the temporal persistence of DDA: brief, intermittent, and prolonged. The intermittent DDA is analogous to intermittent rhythmic delta activity (IRDA). 3) The disorganized type of schizophrenia was frequent in the DDA group and the residual type was frequent in the normal EEG group. 4) The doses of neuroleptics, as well as those of phenothiazines and butyrophenones, were higher in the DDA than in the normal group. 5) The frequency of co-administration of carbamazepine was higher in the DDA than in the normal group, and the rate increased with the degree of abnormality. 6) In a 1 year follow-up of the DDA group, reducing doses of neuroleptics resulted in a tendency for DDA to disappear, and reducing the doses of adjunctive carbamazepine caused DDA to disappear. 7) There was no correlation between DDA and the psychiatric symptoms, intelligence level, or CT findings.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916276     DOI: 10.1177/155005949402500309

Source DB:  PubMed          Journal:  Clin Electroencephalogr        ISSN: 0009-9155


  5 in total

1.  Contrasting EEG profiles elicited by antipsychotic agents in the prefrontal cortex of the conscious rat: antagonism of the effects of clozapine by modafinil.

Authors:  C Sebban; B Tesolin-Decros; M J Millan; M Spedding
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Diffuse electroencephalogram slowing in psychiatric patients: a preliminary report.

Authors:  N N Boutros
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

3.  Separating scale-free and oscillatory components of neural activity in schizophrenia.

Authors:  Frigyes Samuel Racz; Kinga Farkas; Orestis Stylianou; Zalan Kaposzta; Akos Czoch; Peter Mukli; Gabor Csukly; Andras Eke
Journal:  Brain Behav       Date:  2021-02-03       Impact factor: 2.708

Review 4.  Brain NMDA Receptors in Schizophrenia and Depression.

Authors:  Albert Adell
Journal:  Biomolecules       Date:  2020-06-23

5.  High-voltage, diffuse delta rhythms coincide with wakeful consciousness and complexity in Angelman syndrome.

Authors:  Joel Frohlich; Lynne M Bird; John Dell'Italia; Micah A Johnson; Joerg F Hipp; Martin M Monti
Journal:  Neurosci Conscious       Date:  2020-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.